Faculty Disclosures
| Anthony A. Amato, MD, FAAN |
Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abscuro. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caballeta. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Amato has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian Therapeutics. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medpace. Dr. Amato has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firms. The institution of Dr. Amato has received research support from NIH. Dr. Amato has received publishing royalties from a publication relating to health care. |
| Angela L. Genge, MD |
Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for pepgen. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa. |
| Andrew G. Engel, MD, FAAN |
The institution of Dr. Engel has received research support from NIH. |
| Emma Ciafaloni, MD, FAAN |
Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care. |
| Pierre Clavelou, MD, PhD |
Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. |
| Deborah C. Mash, PhD |
No disclosure on file
|
| Giovanni Meola, MD, FAAN |
No disclosure on file
|
|
No disclosure on file
|
| Elisabetta Pagani |
Elisabetta Pagani has nothing to disclose. |
| Valeria A. Sansone, MD |
Dr. Sansone has nothing to disclose. |
| Diana M. Escolar, MD, FAAN |
No disclosure on file
|
| Erik K. Henricson, MPH |
No disclosure on file
|
| Valerie Askanas, MD, PhD, FAAN |
No disclosure on file
|
| Slawomir Wojcik |
No disclosure on file
|
| Christopher Shilling, MS |
No disclosure on file
|
| Jerry R. Mendell, MD, FAAN |
Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta. |
| Sharon Ash |
No disclosure on file
|
| Norman W. Barton, MD, PhD |
Dr. Barton has received personal compensation for serving as an employee of Takeda Pharmaceutical Co. LTD. Dr. Barton has received stock or an ownership interest from Takeda Pharmaceutical Co. LTD. |
| Theresa Michele, MD |
No disclosure on file
|
| Zarife Sahenk, MD, PhD, FAAN |
Dr. Sahenk has nothing to disclose. |
| Brian K. Kaspar, PhD |
No disclosure on file
|
| Jeffery Vance, MD, PhD |
Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics. |
| Eric L. Logigian, MD, FAAN |
Dr. Logigian has nothing to disclose. |
| Richard T. Moxley III, MD, FAAN |
Dr. Moxley has nothing to disclose. |
| Charles A. Thornton, MD, FAAN |
Dr. Thornton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Thornton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Thornton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Thornton has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne. Dr. Thornton has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pepgen. The institution of Dr. Thornton has received research support from Marigold Foundation. The institution of Dr. Thornton has received research support from NIH. The institution of Dr. Thornton has received research support from Muscular Dystrophy Association . The institution of Dr. Thornton has received research support from Dyne. The institution of Dr. Thornton has received research support from Avidity. The institution of Dr. Thornton has received research support from Ionis. Dr. Thornton has received intellectual property interests from a discovery or technology relating to health care. |
| Nuran Dilek |
Nuran Dilek has nothing to disclose. |
| Chiara Briani, MD |
Dr. Briani has nothing to disclose. |
| Raymond Reichwein, MD |
No disclosure on file
|
| Ronald G. Haller, MD |
No disclosure on file
|
| Robert M. Taylor, MD, FAAN |
No disclosure on file
|
| Tanja Taivassalo |
No disclosure on file
|
| Douglas M. Turnbull |
No disclosure on file
|
| Fiona E. Costello, MD |
Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation. |
| Nizar Chahin, MD |
No disclosure on file
|
| Orlando Paciello |
No disclosure on file
|
| William K. Scott, MD |
No disclosure on file
|
| Marta Campagnolo |
No disclosure on file
|
| Gary W. Beecham, PhD |
The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH. |
| Derek Dykxhoorn, PhD |
No disclosure on file
|
| Danielle Blemur |
No disclosure on file
|
| Jon Eliasson |
No disclosure on file
|
| David M. Ermak, DO |
No disclosure on file
|
| Larus S. Gudmundsson, PhD |
No disclosure on file
|
| Syed F. Ali, MD |
No disclosure on file
|
| Lee H. Schwamm, MD, FAAN |
Dr. Schwamm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prime 好色先生. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for lifeimage. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for mediasphere. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medscape/WebMD. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Schwamm has received research support from NINDS. The institution of Dr. Schwamm has received research support from PCORI. Dr. Schwamm has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Schwamm has received publishing royalties from a publication relating to health care. Dr. Schwamm has a non-compensated relationship as a Board of directors with American heart association that is relevant to AAN interests or activities. |
| Frederic Taithe |
No disclosure on file
|
| Sadiqa Mahmood, BDS |
No disclosure on file
|
| Saroja A.O. |
Saroja A.O. has nothing to disclose. |
| Edythe Boitnott |
No disclosure on file
|
| Mohammad H. El-Ghanem, MD |
Dr. El-Ghanem has nothing to disclose. |
| Amre Nouh, MD, FAAN |
Dr. Nouh has stock in Openwater. |
| Amit Haldar, MD, MBBS, DM, FAAN |
Dr. Haldar has nothing to disclose. |
| Susan B. Taboada, NP |
No disclosure on file
|
| Muhammad Niazi, MD |
No disclosure on file
|
| Eve Chanson |
No disclosure on file
|
| Khawja A. Siddiqui, MD |
Dr. Siddiqui has nothing to disclose. |
| Kseniia K. Kriukova |
No disclosure on file
|
| Evgenia Alexandrova, MD |
No disclosure on file
|
| Abigail Cohen |
No disclosure on file
|
| Jeppe Buchbjerg, PhD |
No disclosure on file
|